Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Porcine Circovirus Type 2 Vaccine (SET Technology)
- Development stage
- Preclinical
- Lead developer
- SET Technology
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular
01
Overview
Porcine Circovirus Type 2 Vaccine (SET Technology) is a DNA/RNA-based veterinary vaccine currently in the optimization phase of development by SET Technology. It is designed to protect swine against Porcine Circovirus Type 2 (PCV2), the primary agent responsible for Porcine Circovirus Associated Diseases (PCVAD), such as Postweaning Multisystemic Wasting Syndrome (PMWS). The vaccine utilizes SET Technology's proprietary synthetic expression platform to deliver genetic material encoding PCV2 antigens, thereby stimulating an immune response to prevent infection and associated clinical signs in pigs.
- Other names
- Porcine Circovirus Type 2 (PCV2) VaccinePCV2 VaccinePCV-2 VaccinePCV 2 Vaccine
Beyond the preview
Go deeper on Porcine Circovirus Type 2 Vaccine (SET Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Porcine Circovirus Type 2 Vaccine (SET Technology).